![Farmacia San Polo - FARMACIE, MEDICI: MEDICINA GENERALE RAMO AGOPUNTURA, PROFUMERIA E COSMETICA (PRODUZIONE, INGROSSO), VETERINARI, MEDICAZIONI, Località San Polo - Farmacia San Polo a Localita San Polo - TEL: 055855... - IT100649860 - Infobel locale.IT Farmacia San Polo - FARMACIE, MEDICI: MEDICINA GENERALE RAMO AGOPUNTURA, PROFUMERIA E COSMETICA (PRODUZIONE, INGROSSO), VETERINARI, MEDICAZIONI, Località San Polo - Farmacia San Polo a Localita San Polo - TEL: 055855... - IT100649860 - Infobel locale.IT](https://a.mktgcdn.com/p/ZB5RZP6KDDqV2Uq7V25-ljv-cwtofSrF03j17_Joa3s/400x400.jpg)
Farmacia San Polo - FARMACIE, MEDICI: MEDICINA GENERALE RAMO AGOPUNTURA, PROFUMERIA E COSMETICA (PRODUZIONE, INGROSSO), VETERINARI, MEDICAZIONI, Località San Polo - Farmacia San Polo a Localita San Polo - TEL: 055855... - IT100649860 - Infobel locale.IT
![San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce](https://c8.alamy.com/comp/PW5TY5/san-polo-di-torrile-italy-12th-october-2018-managers-and-workers-of-gsk-and-italian-authorities-inaugurate-the-new-plant-to-produce-fostemsavir-innovative-drug-for-treatment-resistant-hiv-patients-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW5TY5.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce
![San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce San Polo di Torrile, Italy. 12th October, 2018. Managers and workers of GSK and Italian authorities inaugurate the new plant to produce Fostemsavir, innovative drug for treatment-resistant HIV patients. GSK will produce](https://c8.alamy.com/comp/PW5TXA/san-polo-di-torrile-italy-12th-october-2018-managers-and-workers-of-gsk-and-italian-authorities-inaugurate-the-new-plant-to-produce-fostemsavir-innovative-drug-for-treatment-resistant-hiv-patients-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW5TXA.jpg)